Environmental Chemistry Research Group and Public Health Research Group, University of Cartagena, Cartagena 130015, Colombia.
Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), 28015 Madrid, Spain.
Int J Mol Sci. 2020 Jul 8;21(14):4832. doi: 10.3390/ijms21144832.
The urinary arsenic metabolites may vary among individuals and the genetic factors have been reported to explain part of the variation. We assessed the influence of polymorphic variants of Arsenic-3-methyl-transferase and Glutathione-S-transferase on urinary arsenic metabolites. Twenty-two groundwater wells for human consumption from municipalities of Colombia were analyzed for assessed the exposure by lifetime average daily dose (LADD) (µg/kg bw/day). Surveys on 151 participants aged between 18 and 81 years old were applied to collect demographic information and other factors. In addition, genetic polymorphisms (, , , and ) were evaluated by real time and/or conventional PCR. Arsenic metabolites: As, As, monomethylarsonic acid (MMA), and dimethylarsinic acid (DMA) were measured using HPLC-HG-AFS. The influence of polymorphic variants, LADD and other factors were tested using multivariate analyses. The median of total arsenic concentration in groundwater was of 33.3 μg/L and the median of LADD for the high exposure dose was 0.33 µg/kg bw/day. Univariate analyses among arsenic metabolites and genetic polymorphisms showed MMA concentrations higher in heterozygous and/or homozygous genotypes of compared to the wild-type genotype. Besides, DMA concentrations were lower in heterozygous and/or homozygous genotypes of compared to the wild-type genotype. Both DMA and MMA concentrations were higher in genotypes compared to the active genotype. Multivariate analyses showed statistically significant association among interactions gene-gene and gene-covariates to modify the MMA and DMA excretion. Interactions between polymorphic variants * and could be potential modifiers of urinary excretion of arsenic and covariates as age, LADD, and alcohol consumption contribute to largely vary the arsenic individual metabolic capacity in exposed people.
尿液中的砷代谢物可能因个体而异,遗传因素已被报道可以解释部分差异。我们评估了砷 3-甲基转移酶和谷胱甘肽 S-转移酶的多态性变异对尿液中砷代谢物的影响。分析了哥伦比亚 22 个用于人类消费的地下水井,以通过终生平均日剂量 (LADD)(µg/kg bw/day)评估暴露情况。对 151 名年龄在 18 至 81 岁之间的参与者进行了调查,以收集人口统计信息和其他因素。此外,通过实时和/或常规 PCR 评估了遗传多态性(、、、和)。使用 HPLC-HG-AFS 测量砷代谢物:As、As、一甲基砷酸 (MMA) 和二甲基砷酸 (DMA)。使用多变量分析测试了多态性变异、LADD 和其他因素的影响。地下水总砷浓度的中位数为 33.3μg/L,高暴露剂量的 LADD 中位数为 0.33µg/kg bw/day。砷代谢物和遗传多态性的单变量分析显示,与野生型基因型相比,杂合子和/或纯合子基因型的 MMA 浓度更高。此外,与野生型基因型相比,杂合子和/或纯合子基因型的 DMA 浓度更低。与活性基因型相比,基因型的 DMA 和 MMA 浓度更高。多变量分析显示,基因-基因和基因-协变量之间的相互作用与 MMA 和 DMA 排泄的改变具有统计学意义。多态性变异 * 和 之间的相互作用可能是修饰砷排泄的潜在调节剂,协变量如年龄、LADD 和酒精摄入有助于在暴露人群中极大地改变个体的砷代谢能力。